{"id":401849,"date":"2020-12-17T08:48:21","date_gmt":"2020-12-17T13:48:21","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=401849"},"modified":"2020-12-17T08:48:21","modified_gmt":"2020-12-17T13:48:21","slug":"tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/","title":{"rendered":"TOMI Receives Follow-On Order From UK-Based ITH Pharmaceuticals for SteraMist Custom Engineered System"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">FREDERICK, Md., Dec.  17, 2020  (GLOBE NEWSWIRE) &#8212; TOMI Environmental Solutions, Inc.<sup>\u00ae<\/sup> (\u201cTOMI\u201d) (NASDAQ:TOMZ), a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products &#8211; a hydrogen peroxide-based mist and fog composed of ionized<br \/>Hydrogen Peroxide (iHP), today announced that it has received a follow-on order from ITH Pharma Limited (ITH), for the integration of a second SteraMist Custom Engineered System (CES) into their facility.<\/p>\n<p>ITH is an industry leader in aseptic compounding services, mixing drugs into ready-to-use IV preparation, applicable to every area of therapy and strives to set new standards in supplying specialized, manufactured products to medical professionals and their patients. The company must comply with stringent decontamination levels as required by regulatory agencies such as the Medicines and Healthcare products Regulatory Agency (MHRA), and with this order it has purchased an additional SteraMist 8 applicator CES to service their new facility, following initial success with a CES in use with their other refurbished facility. This additional complete room system is in addition to the fleet of 8 Environment Systems initially purchased by ITH, many of which have been recently relocated to an area specifically designated for the manufacturing of COVID-19 testing supplies under the Centers for Disease Control (CDC) procedures. The SteraMist CES utilizes the backbone of all SteraMist equipment: Binary Ionization Technology (BIT) and is permanently mounted into facilities allowing for complete connection to building automation.<\/p>\n<p>Dr. Halden Shane, CEO of TOMI, commented, \u201cWe are excited to work with ITH for an additional CES installation. We have a longstanding relationship with ITH, who recognized the value of our solution early on and was one of the first clients of our Life Sciences division. It can be a time consuming endeavor to adhere to all the GMP and regulatory requirements imposed on pharmaceutical facilities, and we appreciate every opportunity to work with our customers to continue supporting their efforts in both the pandemic and medical supply through our growing range of SteraMist products.\u201d<\/p>\n<p>As an EPA-registered solution to be used exclusively with SteraMist technology, recurring BIT Solution sales are a cornerstone of TOMI\u2019s revenue. Starting in 2021, CES and Environment Systems maintained by ITH Pharma Limited present the opportunity for recurring orders of 100 gallons per month of BIT Solution. These recurring orders allow facilities to maintain uninterrupted focus on specialized operations while also meeting stringent standards in protocols set by agencies such as the National Health Service of the United Kingdom.<\/p>\n<p>\n        <strong>TOMI\u2122 Environmental Solutions, Inc.: Innovating for a safer world<\/strong><br \/>\n        <sup><br \/>\n          <strong>\u00ae<\/strong><br \/>\n        <\/sup>\u00a0<\/p>\n<p>TOMI\u2122\u00a0Environmental Solutions, Inc. (NASDAQ:<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=h5hiHo6R632FumO9EAytvMglZhUFfwRjQelPyqROnrPCbMjf0Vtyu-UQM4OHY-p96-A3EUeAsNY6sjhYVfwQPA==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">TOMZ<\/a>) is a global decontamination and infection prevention company, providing environmental solutions for indoor surface disinfection through the manufacturing, sales and licensing of its premier Binary Ionization Technology<sup>\u00ae<\/sup>\u00a0(BIT<sup>\u2122<\/sup>) platform. Invented under a defense grant in association with the Defense Advanced Research Projects Agency (DARPA) of the U.S. Department of Defense, BIT<sup>\u2122<\/sup>\u00a0solution utilizes a low percentage Hydrogen Peroxide as its only active ingredient to produce a fog of ionized Hydrogen Peroxide (iHP<sup>\u2122<\/sup>). Represented by the SteraMist<sup>\u00ae<\/sup> brand of products, iHP<sup>\u2122<\/sup> produces a germ-killing aerosol that works like a visual non-caustic gas.<\/p>\n<p>TOMI\u00a0products are designed to service a broad spectrum of commercial structures, including, but not limited to, hospitals and medical facilities, cruise ships, office buildings, hotel and motel rooms, schools, restaurants, meat and produce processing facilities, military barracks, police and fire departments, and athletic facilities.\u00a0TOMI\u00a0products and services have also been used in single-family homes and multi-unit residences.<\/p>\n<p>TOMI\u00a0develops training programs and application protocols for its clients and is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, America Seed Trade Association, and The Restoration Industry Association.<\/p>\n<p>For additional information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=WFApt9zal9OXonajsMI-Jwi1pQYXtZvPsADjs-TQrmcIt7UCAxqyfI4W_iebUTJxjIIDsYdMuKrlmIwaD4go83LdKr_bG-9fV6yxD7lV-MI=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">http:\/\/www.tomimist.com\/<\/a>\u00a0or contact us at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RG9hcTtbc50dX9tCItvTGfcz8l-dAADpOuC5_9AVY-Vlm-T5rGTUlw5nuZGr5yVaNKXuwkaHhDjLE6MKVGXzgQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@tomimist.com<\/a>.<\/p>\n<p>\n        <strong>Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 <\/strong>\n      <\/p>\n<p>Certain written and oral statements made by us may constitute \u201cforward-looking statements\u201d as defined in the Private Securities Litigation Reform Act of 1995 (the \u201cReform Act\u201d). Forward-looking statements are identified by such words and phrases as \u201cwe expect,\u201d \u201cexpected to,\u201d \u201cestimates,\u201d \u201cestimated,\u201d \u201ccurrent outlook,\u201d \u201cwe look forward to,\u201d \u201cwould equate to,\u201d \u201cprojects,\u201d \u201cprojections,\u201d \u201cprojected to be,\u201d \u201canticipates,\u201d \u201canticipated,\u201d \u201cwe believe,\u201d \u201ccould be,\u201d and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. They are forward-looking, and they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.<\/p>\n<p>INVESTOR RELATIONS\u00a0CONTACT<\/p>\n<p>John Nesbett\/Jennifer Belodeau<br \/>IMS Investor Relations<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=rAzCSS24Tl5SbxRQPKvd-5Q5bcfhRUIo43ZsJOrWN2Y5OKtvZRxzJkIqh7Q-B22NeF-8E2gFbuBoJqPrTBR2W4K5FJaQOhGgFipV3T-_ZNdhiJvepciT7kRkgceAbEXf\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">jnesbett@imsinvestorrelations.com<\/a><br \/>203.972.9200\u00a0<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNDA4NyMzODg2NjY5IzIwMjc1MzM=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/6bbdcc81-60f8-4cc7-bf8f-bfda9a13bd23\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>FREDERICK, Md., Dec. 17, 2020 (GLOBE NEWSWIRE) &#8212; TOMI Environmental Solutions, Inc.\u00ae (\u201cTOMI\u201d) (NASDAQ:TOMZ), a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products &#8211; a hydrogen peroxide-based mist and fog composed of ionizedHydrogen Peroxide (iHP), today announced that it has received a follow-on order from ITH Pharma Limited (ITH), for the integration of a second SteraMist Custom Engineered System (CES) into their facility. ITH is an industry leader in aseptic compounding services, mixing drugs into ready-to-use IV preparation, applicable to every area of therapy and strives to set new standards in supplying specialized, manufactured products to medical professionals and their patients. The company must comply with stringent decontamination levels &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;TOMI Receives Follow-On Order From UK-Based ITH Pharmaceuticals for SteraMist Custom Engineered System&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-401849","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TOMI Receives Follow-On Order From UK-Based ITH Pharmaceuticals for SteraMist Custom Engineered System - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TOMI Receives Follow-On Order From UK-Based ITH Pharmaceuticals for SteraMist Custom Engineered System - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"FREDERICK, Md., Dec. 17, 2020 (GLOBE NEWSWIRE) &#8212; TOMI Environmental Solutions, Inc.\u00ae (\u201cTOMI\u201d) (NASDAQ:TOMZ), a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products &#8211; a hydrogen peroxide-based mist and fog composed of ionizedHydrogen Peroxide (iHP), today announced that it has received a follow-on order from ITH Pharma Limited (ITH), for the integration of a second SteraMist Custom Engineered System (CES) into their facility. ITH is an industry leader in aseptic compounding services, mixing drugs into ready-to-use IV preparation, applicable to every area of therapy and strives to set new standards in supplying specialized, manufactured products to medical professionals and their patients. The company must comply with stringent decontamination levels &hellip; Continue reading &quot;TOMI Receives Follow-On Order From UK-Based ITH Pharmaceuticals for SteraMist Custom Engineered System&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-17T13:48:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNDA4NyMzODg2NjY5IzIwMjc1MzM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TOMI Receives Follow-On Order From UK-Based ITH Pharmaceuticals for SteraMist Custom Engineered System\",\"datePublished\":\"2020-12-17T13:48:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\\\/\"},\"wordCount\":844,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNDA4NyMzODg2NjY5IzIwMjc1MzM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\\\/\",\"name\":\"TOMI Receives Follow-On Order From UK-Based ITH Pharmaceuticals for SteraMist Custom Engineered System - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNDA4NyMzODg2NjY5IzIwMjc1MzM=\",\"datePublished\":\"2020-12-17T13:48:21+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNDA4NyMzODg2NjY5IzIwMjc1MzM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExNDA4NyMzODg2NjY5IzIwMjc1MzM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TOMI Receives Follow-On Order From UK-Based ITH Pharmaceuticals for SteraMist Custom Engineered System\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TOMI Receives Follow-On Order From UK-Based ITH Pharmaceuticals for SteraMist Custom Engineered System - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/","og_locale":"en_US","og_type":"article","og_title":"TOMI Receives Follow-On Order From UK-Based ITH Pharmaceuticals for SteraMist Custom Engineered System - Market Newsdesk","og_description":"FREDERICK, Md., Dec. 17, 2020 (GLOBE NEWSWIRE) &#8212; TOMI Environmental Solutions, Inc.\u00ae (\u201cTOMI\u201d) (NASDAQ:TOMZ), a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products &#8211; a hydrogen peroxide-based mist and fog composed of ionizedHydrogen Peroxide (iHP), today announced that it has received a follow-on order from ITH Pharma Limited (ITH), for the integration of a second SteraMist Custom Engineered System (CES) into their facility. ITH is an industry leader in aseptic compounding services, mixing drugs into ready-to-use IV preparation, applicable to every area of therapy and strives to set new standards in supplying specialized, manufactured products to medical professionals and their patients. The company must comply with stringent decontamination levels &hellip; Continue reading \"TOMI Receives Follow-On Order From UK-Based ITH Pharmaceuticals for SteraMist Custom Engineered System\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-17T13:48:21+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNDA4NyMzODg2NjY5IzIwMjc1MzM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TOMI Receives Follow-On Order From UK-Based ITH Pharmaceuticals for SteraMist Custom Engineered System","datePublished":"2020-12-17T13:48:21+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/"},"wordCount":844,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNDA4NyMzODg2NjY5IzIwMjc1MzM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/","name":"TOMI Receives Follow-On Order From UK-Based ITH Pharmaceuticals for SteraMist Custom Engineered System - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNDA4NyMzODg2NjY5IzIwMjc1MzM=","datePublished":"2020-12-17T13:48:21+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNDA4NyMzODg2NjY5IzIwMjc1MzM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExNDA4NyMzODg2NjY5IzIwMjc1MzM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tomi-receives-follow-on-order-from-uk-based-ith-pharmaceuticals-for-steramist-custom-engineered-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TOMI Receives Follow-On Order From UK-Based ITH Pharmaceuticals for SteraMist Custom Engineered System"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/401849","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=401849"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/401849\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=401849"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=401849"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=401849"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}